-
Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright
来源: Buzz FX / 10 1月 2025 08:03:15 America/Chicago
Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating restated by
Read more...